LOVE CANNARA BIOTECH INC.

Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike

Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike

MONTREAL, Dec. 16, 2024 (GLOBE NEWSWIRE) -- (“Cannara”, “the Company”, “us” or “we”) () () (), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., that it will be relying on CSA Coordinated Blanket Order 51-913 for an exemption from the requirements to send proxy-related materials for its upcoming annual general meeting (the “Meeting”) to be held on January 30, 2025, at 11:00 a.m. (Montréal time) (the “Proxy-Related Materials”), due to the current delays and suspension of mail service in Canada as a result of the nationwide strike of the Canadian Union of Postal Workers that commenced on November 15, 2024 (the “Postal Strike”).

Access to Documents

The Proxy-Related Materials are available under the Company’s profile on SEDAR+ at or on Cannara’s website at .

Date and Time of the Meeting

The Meeting will be held a virtual-only format, which will be conducted via live audio webcast and teleconference accessible via the following link:

To join the meeting via teleconference, please dial 1-438-797-4001 (Canada) or 1-650-479-3208 (US) and use meeting code 2636 952 9781 and passcode LOVE2025 (56832025 when dialing from a phone or video system). Shareholders accessing the Meeting via teleconference will not be able to vote or speak at the Meeting. To vote or speak at the Meeting, shareholders will need to join the webcast and utilize the chat function during the Meeting. A moderator will be present to allow shareholders to vote or speak at the Meeting at the appropriate time.

Meeting Matters

In addition to receiving the Corporation’s consolidated financial statements for the fiscal year ended August 31, 2024, and the related auditor’s report, shareholders will be invited to vote on the following items at the meeting:

  1. to determine the number of directors and to elect the directors to serve until the Company’s next annual general meeting;
  2. to appoint MNP LLP as auditors of the Company for the ensuing year and to authorize the directors of the Company to fix the remuneration to be paid to the auditors for the ensuing year;
  3. to consider and, if thought fit, to pass an ordinary resolution to approve the Company’s stock option plan, amended, the whole as described in the accompanying management information circular;
  4. to consider and, if thought fit, to pass an ordinary resolution to approve the Company’s restricted share unit compensation plan, the whole as described in the accompanying management information circular;
  5. to transact such other business as may properly come before the Meeting or any adjournment or postponement thereof.

CSA Coordinated Blanket Order 51-913

Recognizing that Postal Strike may impact a reporting issuer’s ability to deliver proxy-related materials to all shareholders, the Canadian Securities Administrators (CSA) published on December 4, 2024, Coordinated Blanket Order 51-931 Temporary Exemption from requirements in National Instrument 51-102 Continuous Disclosure Requirements and National Instrument 54-101 Communication with Beneficial Owners of Securities of a Reporting Issuer to send certain proxy-related materials during a postal strike (“Blanket Order 51-931”), providing temporary relief from the requirement to deliver proxy-related materials for annual meetings.

The conditions in Blanket Order 51-931 include a requirement that each of the matters at the Meeting would be considered an “annual matter”. Cannara confirms that it has complied with all conditions of this exemption.



Assistance

Shareholders of the Company are encouraged to access the Proxy-Related Materials directly through the above-mentioned websites, and registered shareholders and non-objecting beneficial shareholders may contact the Company’s transfer agent, Computershare Investor Services Inc. by calling toll free, within North America - 1-866-962-0498 or direct, from outside of North America - (514) 982-8716 to request copies of the Proxy-Related Materials or 1-800-564-6253 or direct, from outside of North America - 514-982-7555 to request voting control numbers for voting online at . Objecting beneficial shareholders should contact their broker to request their voting instruction forms, voting control numbers and instructions for voting.

In the event that the Postal Strike ends prior to the Meeting, the Company will mail the Proxy-Related Materials in the normal course, but there can be no assurance that the Proxy-Related Materials will be received by the shareholders prior to the Meeting.

ABOUT CANNARA

 () () (), is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec’s low electricity costs, Cannara’s facilities produce premium-grade cannabis products at an affordable price. For more information, please visit .

CONTACT

Nicholas Sosiak, CPA, CA

Chief Financial Officer

  
Zohar Krivorot 

President & Chief Executive Officer 



Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.



EN
16/12/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CANNARA BIOTECH INC.

 PRESS RELEASE

Cannara Biotech annonce des produits et une part de marché nationale r...

Cannara Biotech annonce des produits et une part de marché nationale records pour le premier trimestre 2025, ouvrant la voie à un élan continu en 2025 Produits records : Des produits nets de 25,1 millions de dollars au T1 2025, soit une augmentation de 29 % par rapport aux 19,5 millions de dollars du T1 2024, grâce à une forte demande de produits de cannabis de qualité supérieure.Part de marché record : Part de marché record de 4,1 % au Canada1, soit une augmentation de 28 % d’un trimestre à l’autre et de 58 % par rapport à la même période de l'année précédente, avec des gains dans toutes l...

 PRESS RELEASE

Cannara Biotech Reports Record Q1 2025 Revenue and National Market Sha...

Cannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025 Record Revenue: Net revenues of $25.1 million in Q1 2025, a 29% increase compared to $19.5 million in Q1 2024, driven by strong demand for Cannara’s premium-grade cannabis products.Record Market Share: Achieved Canadian market share of 4.1%1, representing a 28% increase quarter over quarter, and 58% increase over the same period of prior year with gains across all licensed provinces.Robust Profitability: Gross profit before fair value adjustments grew 23% to $9.8 million in Q1...

 PRESS RELEASE

Cannara fait le point sur les documents relatifs à l’assemblée général...

Cannara fait le point sur les documents relatifs à l’assemblée générale annuelle de 2024 dans le contexte de la grève de Postes Canada MONTRÉAL, 16 déc. 2024 (GLOBE NEWSWIRE) -- (« Cannara », « la Société », « nous » ou « notre ») () () (), un producteur verticalement intégré de cannabis et de produits dérivés de qualité supérieure à prix abordable comptant deux méga-installations de culture basées au Québec, couvrant plus de 1 650 000 pieds carrés a annoncé aujourd’hui qu’elle s’appuiera sur la Décision No 2024-PDG-0065 de l’Autorité des marchés financiers pour obtenir une dispense des ...

 PRESS RELEASE

Cannara Provides Update on Its 2024 Annual General Meeting Materials a...

Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike MONTREAL, Dec. 16, 2024 (GLOBE NEWSWIRE) -- (“Cannara”, “the Company”, “us” or “we”) () () (), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., that it will be relying on CSA Coordinated Blanket Order 51-913 for an exemption from the requirements to send proxy-related materials for its upcoming annual general meeting (the “Meeting”) to be held on January 30, 20...

 PRESS RELEASE

Cannara Biotech to Host Investor Webcast on Thursday December 19th, 20...

Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024 MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) -- (“Cannara”, “the Company”, “us” or “we”) () () (), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced that it will host a webcast investor presentation on Thursday, December 19th, 2024, at 2:00 PM ET. During the webcast, Nicholas Sosiak, CFO, will conduct a presentation that will cover key financial and operati...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch